Syntax Research, Inc. Elevance Health, Inc. Transaction History
Syntax Research, Inc.
- $156 Billion
- Q3 2025
A detailed history of Syntax Research, Inc. transactions in Elevance Health, Inc. stock. As of the latest transaction made, Syntax Research, Inc. holds 121 shares of ELV stock, worth $39,425. This represents 0.03% of its overall portfolio holdings.
Number of Shares
121
Previous 3,000
95.97%
Holding current value
$39,425
Previous $1.17 Billion
96.66%
% of portfolio
0.03%
Previous 0.83%
Shares
4 transactions
Others Institutions Holding ELV
# of Institutions
1,779Shares Held
199MCall Options Held
2.38MPut Options Held
2.17M-
Vanguard Group Inc Valley Forge, PA23MShares$7.49 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY20.7MShares$6.75 Billion0.26% of portfolio
-
State Street Corp Boston, MA10.3MShares$3.37 Billion0.12% of portfolio
-
Wellington Management Group LLP Boston, MA6.62MShares$2.16 Billion0.39% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.84MShares$1.9 Billion0.2% of portfolio
About Elevance Health, Inc.
- Ticker ELV
- Exchange NYSE
- Sector Healthcare
- Industry Healthcare Plans
- Shares Outstandng 240,000,992
- Market Cap $78.2B
- Description
- Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....